Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER.
DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and fluid for hydration. Electrolytes are essential for maintaining acid-base balance, osmotic pressure, and normal cellular function. The specific electrolyte composition in this preparation is designed to replace fluids and electrolytes lost in conditions such as diabetic ketoacidosis or other metabolic disorders.
Dextrose provides a source of calories and energy by entering the glycolytic pathway and being metabolized to carbon dioxide and water. Potassium chloride replenishes potassium ions, which are essential for nerve impulse conduction, muscle contraction, and maintaining intracellular osmotic pressure.
Intravenous infusion; rate depends on fluid and electrolyte needs; typical adult maintenance: 100-200 mL/h (2-4 mL/kg/h) of solution providing electrolytes per composition.
Intravenous infusion of potassium chloride 0.3% in dextrose 5% at a rate determined by potassium deficit and patient tolerance, typically 10-20 mEq per hour; maximum infusion rate 40 mEq/hour in non-emergency situations.
None Documented
None Documented
Dextrose: not applicable (endogenous substrate, rapidly cleared by cellular uptake and metabolism). Electrolytes: no true elimination half-life; distribution and renal clearance follow physiological kinetics. For infused solutions, clinical half-life of volume expansion is distribution-dependent, approximately 20–30 minutes for initial equilibration.
Not applicable as a single drug; potassium's terminal half-life ~12-24 hours (depends on total body stores and renal function); dextrose half-life ~15-20 minutes (highly variable with insulin response). Clinical context: half-life relevant only for potassium monitoring in renal impairment.
Dextrose is completely metabolized to carbon dioxide and water; no renal/biliary excretion of intact molecule. Electrolytes (Na+, K+, Mg2+, Cl-, acetate, gluconate) are eliminated renally (primarily) and via sweat/feces. Renal excretion of Na+ and Cl- exceeds 90% under normal renal function. Acetate is rapidly oxidized to bicarbonate, with <1% excreted unchanged. Gluconate is metabolized or excreted renally.
Potassium: >90% renal excretion. Dextrose: metabolized to CO2 and water; no significant renal excretion of intact glucose unless hyperglycemia exceeds renal threshold.
Category C
Category C
IV Fluid
IV Fluid